Zymocort Overdosage

Concise Prescribing Info Full Prescribing Info Contents Description Action Indications/Uses Dosage/Direction for Use Overdosage Contraindications Special Precautions Use In Pregnancy & Lactation Adverse Reactions Storage MIMS Class ATC Classification Regulatory Classification Presentation/Packing

Full Prescribing Info

Overdosage

Because of the negligible (≤0.1%) systemic bioavailabilty of Mometasone Furoate (Zymocort), overdose is unlikely to require any therapy other than observation, followed by initiation of the appropriate prescribed dosage inhalation or oral administration of excessive doses of corticosteroid may lead to suppression of HPA axis function.

mometasone

Manufacturer:

Alvita Pharma

Distributor:

Cathay Drug

Marketer:

MedEthix